Whether use of non-calcium-containing phosphate binders versus calcium-containing phosphate binders improves outcomes for patients with chronic kidney disease is unclear. Now, new data from an open-label randomized controlled trial suggest that the non-calcium-containing phosphate binder sevelamer hydrochloride significantly improves survival compared to calcium carbonate in incident patients on haemodialysis.
- Adrian Covic
- Luminita Voroneanu
